Relypsa Funds Three Innovative Research Projects on Hyperkalemia and Associated Disorders

World News: . []

REDWOOD CITY, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- Relypsa, Inc., a Vifor Pharma Group company, today announced that it has awarded three research grants to supplement institutional funding for nephrology and/or cardiology fellows pursuing a career in the area of hyperkalemia and associated disorders. Relypsa will fund the grant awards of up to $50,000 each for one academic year. Institutions receiving the research grants include the University of Cincinnati, Emory University and the University of Chicago.

“Our research grants aim to improve patient care, encourage disease awareness and educate healthcare organizations and professionals,” said Alain Romero, Ph.D., Pharm.D., vice president of medical and scientific affairs of Relypsa. “We are excited for the recipients of the Relypsa Nephrology and Cardiology Research Grant Program and look forward to seeing the results of their research.”

Relypsa’s grants will fund research in areas vital to improving the care of patients with kidney and heart diseases, including: 1) Defining with greater accuracy the frequency of hyperkalemia in solid organ transplant recipients and correlating their hyperkalemia episodes to clinical episodes; 2) Exploring the influence of potassium and urea levels on fibrosis in animal models of renal dysfunction; and 3) Following patients prospectively at a single site who require treatment with either a renin angiotensin system blocker and/or a mineralocorticoid receptor antagonist to improve blood pressure and/or cardiac function.

More news and information about Relypsa, Inc.

Published By:

Globe Newswire: 21:00 GMT Monday 16th April 2018

Published: .

Search for other references to "relypsa" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers